BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Deals

  Abbott Laboratories Buys AP214 Hormone From Action Pharma for $110 Million

  May 3, 2012

   · 

  4 min read
• Business

  Merck & Co., Inc. Investing $15 Million in Facility to Take on More Vaccines

  May 3, 2012

   · 

  1 min read
• Deals

  Royalty Pharma Buys an Interest in Fumaderm for $761 Million Cash

  May 3, 2012

   · 

  2 min read
• Drug Development

  Idera Pharmaceuticals, Inc.'s IMO-2055 Disappoints in Phase 2 Study

  May 3, 2012

   · 

  8 min read
• Abbott Laboratories Pins Hope on Consumer Products Post Split

  May 3, 2012

   · 

  1 min read
• Job Trends

  Medtronic, Inc. Laying Off 220 Twin Cities Employees

  May 3, 2012

   · 

  1 min read
• Drug Development

  Studies Reveal How Merck & Co., Inc.'s Vioxx Raises Heart Risks

  May 3, 2012

   · 

  1 min read
• DNA Genotek Announces Recipients of the DNA Genotek Grant Program

  May 3, 2012

   · 

  4 min read
• Business

  Kensey Nash Corporation Reports Third Quarter Fiscal Year 2012 Financial Results

  May 3, 2012

   · 

  2 min read
• Deals

  Kensey Nash Corporation Agrees to Be Acquired by Royal DSM for $38.50 per Share in Cash

  May 3, 2012

   · 

  7 min read